ChemoCentryx Inc. (CCXI)

10.95 0 (0%)

IEX Real-Time Price

August 16, 2018 EST.

Nasdaq Global Select : Healthcare

Prev Close 10.95

Price Open 11.49

Volume: 140,378

Avg Volume: 175,684

Market Cap: 551.65M

P/E Ratio 32.21

52 Wk Range 5.42-15.08



CCXI Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-07-31
46.29M
2.5M
14.09
5.40%

2018-07-13
46.29M
2.48M
7.55
5.36%

2018-06-29
46.29M
2.51M
6.31
5.43%

2018-06-15
46.32M
2.54M
6.98
5.49%




CCXI Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-05-09
Q1 2018
N/A
-0.29 (2)
-0.19
0.06

2018-03-13
Q4 2017
N/A
-0.22 (2)
-0.19
0.06

2018-03-09
Q4 2017
BTO
-0.22 (2)
-0.19
0.06

2017-11-07
Q3 2017
AMC
-0.28 (2)
-0.19
0.06

News

ChemoCentryx 2018 Q2 - Results - Earnings Call Slides (2018-08-10 15:16 SeekingAlpha)

The following slide deck was published by ChemoCentryx in conjunction with their 2018 Q2 earnings Read more …

 

ChemoCentryx, Inc. (CCXI) CEO Dr. Thomas Schall on Q2 2018 Results - Earnings Call Transcript (2018-08-09 23:36 SeekingAlpha)

ChemoCentryx, Inc. (CCXI) Q2 2018 Results Earnings Conference Call August 09, 2018 05:00 PM ET Executives Steve Klass - VP, Burns McClellan Dr. Thomas Schall - President and CEO Susan Kanaya - EVP and Chief Financial and Administrative Officer Bill Fairey - COO Analysts K…

 


Statistics

Shares Outstanding: 50.38M

Top 15 Institution Percent: 49.80

Price To Sales: 6.39

Price To Book: 19.89

Revenue: 9.03M

Gross Profit: N/A

Cash: 120.56M

Debt: N/A

Return On Assets: 9.68

Return On Equity: 48.14

Profit Margin: 18.69

Price History

Beta: 1.32

50-day Moving Avg: 12.27

200-day Moving Avg: 10.33

YTD Change: 85.59

5-day Change: -8.37

1-month Change: -13.85

3-month Change: -12.40

6-month Change: 15.63

1-year Change: 51.03

Revenue Per Share: 0.00

Revenue Per Employee: 136803.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: ChemoCentryx Inc.

Exchange: Nasdaq Global Select

Industry: Biotechnology

Sector: Healthcare

Website: http://www.chemocentryx.com

ChemoCentryx Inc is a biopharmaceutical company. It is engaged in discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer.